Editorials |
From INSERM U769, Châtenay-Malabry, F-92296 France, and Université Paris-Sud, Faculté de Pharmacie, IFR141, Châtenay-Malabry, F-92286 France.
Correspondence to Rodolphe FISCHMEISTER, INSERM U769, Faculté de Pharmacie, 5, Rue J.-B. Clément, F-92296 Châtenay-Malabry Cedex, France. E-mail fisch@vjf.inserm.fr
See related article, pages 675681
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Endothelium of the vascular system forms a semipermeable barrier between blood and the interstitial space that serves to control and restrict the luminal to abluminal movement of water, plasma proteins, and other solutes.1 During inflammation, mediators such as thrombin, histamine, and platelet activating factor (PAF) induce vascular leakage defined as an increased endothelial permeability to plasma proteins. In the lung, disruption of the barrier formed by pulmonary microvascular endothelial cells (PMVECs) occurs during inflammatory disease states such as acute lung injury and acute respiratory distress syndrome. Endothelial permeability to macromolecules occurs via the formation of small gaps between (paracellular) or through (transcellular) cells and is controlled by cell shape and cell adhesion through a balance of opposite mechanical forces; contractile forces generated by actomyosin motor function, tethering forces generated by adhesive proteins at the cellcell border, and focal adhesions at the cellmatrix border.2 Because of its central role in mechanical processes, Ca2+ is an important regulator of endothelial permeability. Intracellular Ca2+ concentration ([Ca2+]i) is increased in PMVECs on binding of proinflammatory mediators to their respective membrane receptors, and subsequent activation of the Gq proteinmediated signaling cascade. In particular, this rise in [Ca2+]i is essential for the generation of endothelial cell paracellular gaps. Other downstream major actors in this Ca2+-sensitizing cascade include PKC, Ca2+-dependent myosin light chain kinase (MLCK), and the monomeric GTPase RhoA.
Whereas elevated [Ca2+]i increases endothelial barrier permeability, increased cAMP has the opposite effect.3 Changes in this ubiquitous second messenger are governed
Related Article:
Circ. Res. 2006 98: 675-681.
This article has been cited by other articles:
![]() |
J. C. Moore and Z. K. Ballas A Novel Therapy for Lymphedema Arch Intern Med, January 26, 2009; 169(2): 201 - 202. [Full Text] [PDF] |
||||
![]() |
R. H. Adamson, J. C. Ly, R. K. Sarai, J. F. Lenz, A. Altangerel, D. Drenckhahn, and F. E. Curry Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1188 - H1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Creighton, B. Zhu, M. Alexeyev, and T. Stevens Spectrin-anchored phosphodiesterase 4D4 restricts cAMP from disrupting microtubules and inducing endothelial cell gap formation J. Cell Sci., January 1, 2008; 121(1): 110 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Houslay, G. S. Baillie, and D. H. Maurice cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling Circ. Res., April 13, 2007; 100(7): 950 - 966. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |